Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome
Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequ...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wolters Kluwer Medknow Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19e260343d6646d3937cfdde1af57397 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:19e260343d6646d3937cfdde1af57397 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:19e260343d6646d3937cfdde1af573972021-11-12T10:10:38ZHomocysteine and C-reactive protein levels in women with polycystic ovary syndrome2213-307010.4103/GMIT.GMIT_30_20https://doaj.org/article/19e260343d6646d3937cfdde1af573972021-01-01T00:00:00Zhttp://www.e-gmit.com/article.asp?issn=2213-3070;year=2021;volume=10;issue=4;spage=210;epage=214;aulast=Gözüküçükhttps://doaj.org/toc/2213-3070Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequela. The aim of this study is to evaluate serum homocysteine (Hcy) and C-reactive protein (CRP) levels in women with PCOS and to evaluate their relationship with clinical and laboratory parameters in women with PCOS.Materials and Methods: The prospective single-center study included 45 women with PCOS (study group) and 41 control subjects. Demographic variables and Hcy, CRP, fasting blood glucose, insulin, follicle-stimulating hormone, luteinizing hormone, estradiol, total and free testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone levels, and lipid profiles of the subjects were recorded. homeostatic model assessment for insulin resistance (HOMA-IR) indexes were calculated.Results: Fasting plasma glucose, insulin, HOMA-IR, free and total testosterone levels, and clinical hirsutism were significantly higher in the study group. There was no statistically significant difference in lipid profile between groups. Hcy and CRP levels were higher in the study group, which was not statistically significantly different (P > 0.05).Conclusion: Some of the parameters that are correlated with CVD risk were found to be higher in women with PCOS, although the difference for Hcy and CRP did not reach statistical significance. However, the current study reveals that the CVD risk associated with PCOS deserves more comprehensive prospective studies with long-term outcomes.Murat GözüküçükAslı Yarcı GürsoyEmre DestegülSalih TaşkİnHakan ŞatıroğluWolters Kluwer Medknow Publicationsarticlec-reactive proteinhomocysteinepolycystic ovary syndromeGynecology and obstetricsRG1-991ENGynecology and Minimally Invasive Therapy, Vol 10, Iss 4, Pp 210-214 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
c-reactive protein homocysteine polycystic ovary syndrome Gynecology and obstetrics RG1-991 |
spellingShingle |
c-reactive protein homocysteine polycystic ovary syndrome Gynecology and obstetrics RG1-991 Murat Gözüküçük Aslı Yarcı Gürsoy Emre Destegül Salih Taşkİn Hakan Şatıroğlu Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
description |
Objectives: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in infertile women characterized by both reproductive and metabolic dysfunctions of different degrees. Furthermore, it has been associated with increased cardiovascular disease (CVD) risk and related long-term health sequela. The aim of this study is to evaluate serum homocysteine (Hcy) and C-reactive protein (CRP) levels in women with PCOS and to evaluate their relationship with clinical and laboratory parameters in women with PCOS.Materials and Methods: The prospective single-center study included 45 women with PCOS (study group) and 41 control subjects. Demographic variables and Hcy, CRP, fasting blood glucose, insulin, follicle-stimulating hormone, luteinizing hormone, estradiol, total and free testosterone, dehydroepiandrosterone sulfate, thyroid-stimulating hormone levels, and lipid profiles of the subjects were recorded. homeostatic model assessment for insulin resistance (HOMA-IR) indexes were calculated.Results: Fasting plasma glucose, insulin, HOMA-IR, free and total testosterone levels, and clinical hirsutism were significantly higher in the study group. There was no statistically significant difference in lipid profile between groups. Hcy and CRP levels were higher in the study group, which was not statistically significantly different (P > 0.05).Conclusion: Some of the parameters that are correlated with CVD risk were found to be higher in women with PCOS, although the difference for Hcy and CRP did not reach statistical significance. However, the current study reveals that the CVD risk associated with PCOS deserves more comprehensive prospective studies with long-term outcomes. |
format |
article |
author |
Murat Gözüküçük Aslı Yarcı Gürsoy Emre Destegül Salih Taşkİn Hakan Şatıroğlu |
author_facet |
Murat Gözüküçük Aslı Yarcı Gürsoy Emre Destegül Salih Taşkİn Hakan Şatıroğlu |
author_sort |
Murat Gözüküçük |
title |
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
title_short |
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
title_full |
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
title_fullStr |
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
title_full_unstemmed |
Homocysteine and C-reactive protein levels in women with polycystic ovary syndrome |
title_sort |
homocysteine and c-reactive protein levels in women with polycystic ovary syndrome |
publisher |
Wolters Kluwer Medknow Publications |
publishDate |
2021 |
url |
https://doaj.org/article/19e260343d6646d3937cfdde1af57397 |
work_keys_str_mv |
AT muratgozukucuk homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome AT aslıyarcıgursoy homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome AT emredestegul homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome AT salihtaskin homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome AT hakansatıroglu homocysteineandcreactiveproteinlevelsinwomenwithpolycysticovarysyndrome |
_version_ |
1718430974722703360 |